活化T细胞核因子1在胰腺可塑性中的情境依赖性表观遗传调控
该研究在小鼠及人胰腺组织与细胞中探讨了活化T细胞核因子1(NFATC1)在胰腺再生与恶性转化中的情境依赖性调控。NFATC1在腺泡细胞损伤早期快速短暂诱导,促进转分化并抑制化生细胞增殖;再生晚期EZH2依赖的组蛋白甲基化沉默Nfatc1以利 redifferentiation。KRAS致癌激活逆转EZH2对NFATC1基因的作用,并需要EZH2介导的NFATC1转录激活。作者认为EZH2抑制剂可能干扰NFATC1致癌活性并用于胰腺导管腺癌治疗。
要点
- NFATC1在腺泡细胞损伤早期快速短暂诱导,促进腺泡细胞转分化并抑制化生胰腺细胞增殖。
- 再生晚期EZH2依赖的组蛋白甲基化沉默Nfatc1,以利腺泡细胞再分化并防止器官萎缩和外分泌功能不全。
- 胰腺导管腺癌细胞中KRAS致癌激活逆转EZH2对NFATC1基因的效应,并需要EZH2介导的NFATC1转录激活。
核心结论
- 在人及小鼠胰腺细胞和组织研究中,作者识别出NFATC1活性的情境特异性表观遗传调控是胰腺细胞可塑性的重要机制。
- 作者认为EZH2抑制剂可能干扰NFATC1的致癌活性并用于胰腺导管腺癌治疗。
研究设计与样本
- 研究分析了胰腺特异性表达组成性激活型NFATC1或分别敲除增强子zeste同源物2(EZH2)的小鼠(分别在野生型或组成性激活Kras背景下)胰腺再生与转化过程中的细胞可塑性。
- 通过腹腔注射雨蛙素诱导急性和慢性胰腺炎。
- 用免疫组化、免疫印迹和定量逆转录聚合酶链反应研究小鼠及人胰腺组织和细胞中EZH2依赖的NFATC1表达调控。
- 采用遗传学和药理学方法抑制EZH2和NFATC1,研究通路破坏对胰腺形态和功能的影响。
- 通过染色质免疫沉淀试验研究NFATC1基因的表观遗传修饰。
主要发现
- NFATC1在人样本和小鼠中对腺泡细胞损伤的早期适应中快速短暂诱导,促进腺泡细胞转分化并阻断化生胰腺细胞的增殖。
- 在再生晚期,Nfatc1被EZH2依赖的组蛋白甲基化表观遗传沉默,以实现腺泡细胞再分化并防止器官萎缩和外分泌功能不全。
- 在胰腺导管腺癌细胞中,KRAS信号的致癌激活逆转了EZH2对NFATC1基因的效应,并且是EZH2介导的NFATC1转录激活所必需的。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The ability of exocrine pancreatic cells to change the cellular phenotype is required for tissue regeneration upon injury, but also contributes to their malignant transformation and tumor progression. We investigated context-dependent signaling and transcription mechanisms that determine pancreatic cell fate decisions toward regeneration and malignancy. In particular, we studied the function and regulation of the inflammatory transcription factor nuclear factor of activated T cells 1 (NFATC1) in pancreatic cell plasticity and tissue adaptation. METHODS: We analyzed cell plasticity during pancreatic regeneration and transformation in mice with pancreas-specific expression of a constitutively active form of NFATC1, or depletion of enhancer of zeste 2 homologue 2 (EZH2), in the context of wild-type or constitutively activate Kras, respectively. Acute and chronic pancreatitis were induced by intraperitoneal injection of caerulein. EZH2-dependent regulation of NFATC1 expression was studied in mouse in human pancreatic tissue and cells by immunohistochemistry, immunoblotting, and quantitative reverse transcription polymerase chain reaction. We used genetic and pharmacologic approaches of EZH2 and NFATC1 inhibition to study the consequences of pathway disruption on pancreatic morphology and function. Epigenetic modifications on the NFATC1 gene were investigated by chromatin immunoprecipitation assays. RESULTS: NFATC1 was rapidly and transiently induced in early adaptation to acinar cell injury in human samples and in mice, where it promoted acinar cell transdifferentiation and blocked proliferation of metaplastic pancreatic cells. However, in late stages of regeneration, Nfatc1 was epigenetically silenced by EZH2-dependent histone methylation, to enable acinar cell redifferentiation and prevent organ atrophy and exocrine insufficiency. In contrast, oncogenic activation of KRAS signaling in pancreatic ductal adenocarcinoma cells reversed the EZH2-dependent effects on the NFATC1 gene and was required for EZH2-mediated transcriptional activation of NFATC1. CONCLUSIONS: In studies of human and mouse pancreatic cells and tissue, we identified context-specific epigenetic regulation of NFATc1 activity as an important mechanism of pancreatic cell plasticity. Inhibitors of EZH2 might therefore interfere with oncogenic activity of NFATC1 and be used in treatment of pancreatic ductal adenocarcinoma.
引用
- Chen NM, Neesse A, Dyck ML, et al. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity. Gastroenterology. 2017. PMID: 28188746. doi:10.1053/j.gastro.2017.01.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。